
    
      Doses are escalated based on safety assessments: As soon as a dose meets the criteria for
      "tolerated" or "not tolerated", doses are escalated or terminated, respectively. All patients
      are treated for 2 weeks, with follow-up visits scheduled 1 week and 1 month post-treatment.
    
  